In this episode of On The Line, host Matt Gurney is joined by two guests to discuss hockey, inflation, politics, and whether Canada can finally get serious about building major infrastructure.
This episode is brought to you by BioCanRx. We’ve been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This month we’re addressing common questions, like: do these therapies have export potential?
The farthest advanced BioCanRx-supported therapies are still in clinical trials here in Canada, but other countries are already expressing interest based on their efficacy and lower cost. Canadian-developed CAR-T technology from the CLIC group is already being used to treat clinical trial patients in Denmark, and other countries with high numbers of leukemia cases have expressed interest. A successful clinical trial in another country can be an important first step toward bringing that therapy to market there. If BioCanRx-supported therapies continue to be trialed outside Canada, it sends a strong signal that made-in-Canada immunotherapies will find a receptive international market.
Thanks to BioCanRx for continuing to partner with The Line to share this information. Visit BioCanRx.com to learn more.
First up is Scott Stinson, a contributor to The Line and columnist with the National Post. In theory, Matt and Scott are here to talk about hockey, and how prime minister Mark Carney has been using Canada’s national game as an instrument of geopolitical power — with some success so far. And they do talk about that! But breaking news intrudes on their plans to have a more relaxed episode, with new inflation numbers coming in hotter than expected. Rising gasoline prices are part of the story, so this isn’t a shock, but Matt and Scott discuss the bigger political problem facing Carney. As the immediate threat from Donald Trump (maybe) begins to recede, Canadians are increasingly focused on the cost of living. What happens to Carney’s political fortunes when voters stop worrying quite so much about Trump and start wondering why everything has become so expensive?
The episode is also brought to you by the Forest Products Association of Canada. For years, the Forest Products Association of Canada has called for action to reduce regulatory duplication and create greater certainty for mills, factories, and investment. We’re encouraged to see the federal government taking action to make Canada’s regulatory system more coordinated and predictable, removing made-in-Canada barriers that have held the sector back. This is an important step for forestry and for communities across the country that depend on the sector.
Now, we need to move from promises to production. Canadian jobs, stronger supply chains, and new opportunities for communities from coast to coast to coast depend on it.
Canada’s forest sector is ready to do its part. Learn more at FPAC.ca.
Then Matt is joined by Alan Findlay, The Line’s newest hire and first-ever reporter. Alan is spending the next year investigating what works, what doesn’t, and why Canada has such a difficult time getting big things done. His first story, published just a few days ago, examines Alto, the proposed high-speed rail system. Alan walks Matt through what he learned while reporting the piece, including the biggest threats facing the project, the obstacles that could derail it, and some surprisingly encouraging signs that Canada might actually get this one right.
This episode is also brought to you by Cameco. Building Canada’s energy future means creating jobs for Canadian workers. That’s why the AP1000 reactor is the right choice for Canada: it is already operating and ready to deliver the power we need. Choosing the AP1000 means a reactor built by Canadians, creating skilled jobs in construction, fabrication and the trades while keeping more investment and economic benefits here at home. If we are serious about creating Canadian jobs and strengthening our economy, the choice is clear. To learn more, visit ap1000.cameco.com.
Be sure to check out Alan’s report. And as always, like and subscribe!
YouTube:
Video goes live at 7 p.m Eastern/5 Mountain.
Spotify:
Apple:
Enjoy the episode! Talk to you soon.
The Line is entirely reader and advertiser funded. No federal subsidies, no bailouts. If you value our work, please consider supporting us by subscribing or making a donation. Donations are not subscriptions and do not unlock paywalled content, but they help keep The Line independent
To contact The Line with a general inquiry or comment, please email info@readtheline.ca. For other ways to connect with us or to follow us on social media, please see our LinkTree.














